Hosted on MSN2mon
GSK buys US-based rare cancer treatment developer for up to £1bnaccording to the American Cancer Society. GSK’s acquisition of IDRx will include IDRX-42 which is currently being developed and trialled as therapy for the treatment of gastrointestinal stomal ...
GlaxoSmithKline (GSK) plans to take a blood cancer antibody ... pre-treated multiple myeloma patients, presented at the American Society for Hematology (ASH) conference, was therefore hotly ...
Novartis has teamed up with the NFL in a multi-year partnership, marking the first such collaboration between the football ...
OWN, through its health initiative OWN Your Health, has partnered with the American Cancer Society's VOICES of Black Women campaign.
The results were featured at the American Society of Haematology (ASH) annual meeting and, according to GSK, "support the potential ... treatment for the blood cancer. After being all but written ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results